UbiqueBio is a biotechnology company dedicated to making diagnostics available everywhere. We are developing human infectious diseases reagents and technology using immunochemistry and synthetic peptides. Our technology is based on particle interaction principles that combined with simple devices enable the detection of target pathogens. UbiqueBio’s expertise extends from antigen discovery using AI & machine learning, microarrays, and peptide libraries to assay development, clinical studies, and validation. Our technology applies to a wide range of disease targets and applications.